AUTHOR: Relindis Azenwi Fru, MD
Porphyrias are rare inherited (mostly autosomal dominant) disorders due to deficiencies of heme synthesis enzymes. Table E1 classifies the various types. They are named after the Greek word porphurus (purple), after the red fluorescence of porphyrins exposed to ultraviolet light.
Table E2 summarizes the various types of porphyrias.
Acute intermittent porphyria (AIP)
Hereditary coproporphyria (HCP)
Congenital erythropoietic porphyria (CEP)
Hepatoerythropoietic porphyria
| ||||||||
Equal female-to-male ratio, except for AIP (female predominance). Pubertal onset is common.
Acute intermittent porphyria is more prevalent in northern Sweden (1:1000); variegate porphyria is more common in descendants of Dutch settlers from South Africa (both due to founder effect).
There are two broad categories of acute porphyrias. These include:
AIP is the most common form of the four neurovisceral porphyrias. It is inherited in an autosomal dominant fashion. The disorder occurs via deficiency of the enzyme porphobilinogen deaminase, which is the third enzyme in the heme biosynthetic pathway. Patients typically present with severe abdominal pain, nausea, vomiting, dark urine, +/anemia, and otherwise a negative workup. They can also present with urinary retention, neurologic symptoms (sensory, motor, autonomic dysfunction).
Oral contraceptive pills or sex hormones, tobacco abuse, malnutrition, and stress can exacerbate or precipitate symptoms of AIP.
The diagnosis of AIP is confirmed by decreased erythrocyte PBG deaminase activity and/or mutation in the gene encoding PBGD (hydroxymethylbilane synthase).
These disorders are in the differential of acute abdomen; however, characteristically, rebound tenderness is not present.
TABLE E1 Porphyrias: Clinical Involvement, Enzymatic Etiology, and Chromosomal Location
| Porphyria (Synonym) | Acute Attack, Skin and Organ Involvement | Enzyme of Heme Biosynthesis Affected | Chromosome Location |
|---|---|---|---|
| X-linked sideroblastic anemia | Bone marrow | 5-Aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS2) | Xp11.21 |
| X-linked dominant protoporphyria | Skin, red cells, liver | 5-Aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS2) | Xp11.21 |
| ALA dehydratase deficiency porphyria (plumboporphyria) | Acute liver | ALA dehydratase (porphobilinogen synthase) | 9q33.1 |
| Acute intermittent porphyria (intermittent acute porphyria) | Acute liver | Porphobilinogen deaminase (hydroxymethylbilane synthase) | 11q23.3 |
| Congenital erythropoietic porphyria (Günther disease) | Skin, red cells, bone marrow | Uroporphyrinogen III synthase | 10q25.2-q26.3 |
| Porphyria cutanea tarda (symptomatic porphyria, cutaneous hepatic porphyria) | Skin, liver | Uroporphyrinogen decarboxylase | 1p34 |
| Hereditary coproporphyria | Acute skin, liver | Coproporphyrinogen oxidase | 3q12 |
| Variegate porphyria (porphyria variegata) | Acute skin, liver | Protoporphyrinogen oxidase | 1q22 |
| Erythropoietic protoporphyria (erythrohepatic protoporphyria) | Skin, red cells, liver | Ferrochelatase (heme synthase) | 18q21.3 |
ALA, 5-Aminolevulinate.From Hoffman R et al: Hematology: basic principles and practice, ed 7, Philadelphia, 2018, Elsevier.
TABLE E2 Classification of Porphyrias
| Classification | Disease | Biochemistry | Clinical Features |
|---|---|---|---|
| Acute porphyria | Acute intermittent porphyria | Increased ALA and PBG | Acute attack |
| Variegate porphyria | Increased ALA and PBG; increased porphyrin | Acute attack; photosensitivity | |
| Hereditary coproporphyria | Increased ALA and PBG; increased porphyrin | Acute attack; photosensitivity | |
| ALA dehydratase deficiency porphyria | Increased ALA; increased porphyrin | Acute and chronic neuropathy | |
| Nonacute porphyria | Porphyria cutanea tarda | Increased porphyrin | Photosensitivity |
| Erythropoietic protoporphyria | Increased porphyrin | Photosensitivity | |
| Congenital erythropoietic porphyria | Increased porphyrin | Photosensitivity | |
| X-linked dominant protoporphyria | Increased porphyrin | Photosensitivity | |
| Porphyrinurias | Lead, alcohol, iron deficiency anemia, liver disease | Various biochemical manifestations | Various clinical presentations |
ALA, 5-Aminolevulinate; PBG, porphobilinogen.
From Hoffman R et al: Hematology: basic principles and practice, ed 7, Philadelphia, 2018, Elsevier.
Figure E1 Porphyria cutanea tarda.
Eroded blisters and crusts.
Courtesy the Yale Residents Collection. From Skorecki K et al: Brenner & Rectors the kidney, ed 10, Philadelphia, 2016, Elsevier.
Of note, if PBG is substantially elevated, plasma and stool samples can be obtained and sent for porphyrin measurements while treatment with hemin is started.
TABLE E3 Changes in Porphyrins and Their Precursors in the Porphyrias, Porphyrinurias, and Hereditary Sideroblastic Anemia
| Porphyrias and Other Conditions | ALA | PBG | Urine Uroporphyrin | Urine Coproporphyrin | Feces Coproporphyrin | Feces Protoporphyrin | Erythrocyte Protoporphyrin |
|---|---|---|---|---|---|---|---|
| Acute Porphyrias | |||||||
| Acute intermittent porphyria | Raised, very high in attack | Raised, very high in attack | Usually raiseda | Sometimes raised | Sometimes raised | Sometimes raised | Normal |
| Variegate porphyria | Raised in attack | Raised in attack | Usually raised in attack | Usually raised in attack | Raised | Raised | Normal |
| Hereditary coproporphyria | Raised in attack | Raised in attack | Sometimes raised in attack | Usually raised, always in attack | Raised | Usually normal | Normal |
| ALA dehydratase-deficiency porphyria | Raised in attack | Normal | Normal | Usually raised in attack | Normal | Normal | Occasionally raised |
| Nonacute Porphyrias | |||||||
| Porphyria cutanea tarda | Normal | Normal | Raised (7-/8- carboxylate porphyrin levels very high in attack) | Slightly raised | Isocoproporphyrin raised in remission | Raised in remission | Normal |
| Erythropoietic protoporphyria | Normal | Normal | Normal | Normal | Normal | Usually raised | Raised, usually very high |
| Congenital erythropoietic porphyria | Usually normal | Usually normal | Raised, isomer I | Raised, isomer I | Normal | Usually raised | Usually raised |
| X-linked dominant protoporphyria | Normal | Normal | Normal | Normal | Normal | Usually raised | Raised, usually very high |
| Other Conditions | |||||||
| Hereditary sideroblastic anemia | Normal | Normal | Normal | Normal | Normal | Normal | Occasionally raised |
| Lead poisoning | Raised | Normal | Normal | Sometimes raised | Normal | Normal | Raised when blood lead level >2 μM |
| Hereditary tyrosinemia | Raised | Normal | Normal | Normal | Normal | Normal | Normal |
| Iron deficiency anemia | Normal | Normal | Normal | Normal | Normal | Normal | Raised |
ALA, 5-Aminolevulinate; PBG, porphobilinogen.
From Hoffman R et al: Hematology: basic principles and practice, ed 7, Philadelphia, 2018, Elsevier.
TABLE E4 Precipitating Factors in Acute Porphyria
| Drugs | Other Stimuli | ||
| Alcohol | Fasting or dieting | ||
| Barbiturates | Hormones, stress | ||
| Angiotensin-converting enzyme (ACE) inhibitors | Smoking | ||
| Anticonvulsants | |||
| Antidepressants | |||
| Calcium channel blockers | |||
| Cephalosporins | |||
| Ergot derivatives | |||
| Erythromycin | |||
| Steroids or anabolic steroids | |||
| Contraceptives, hormone replacement therapy | |||
| Sulfonamides | |||
| Sulfonylureas |
From Hoffman R et al: Hematology: basic principles and practice, ed 7, Philadelphia, 2018, Elsevier.